Brompton Global Healthcare Income & Growth ETF (TSX:HIG)
Assets | 53.69M |
Expense Ratio | 1.09% |
PE Ratio | 27.39 |
Dividend (ttm) | 0.66 |
Dividend Yield | 8.54% |
Ex-Dividend Date | May 30, 2025 |
Payout Frequency | Monthly |
Payout Ratio | 233.53% |
1-Year Return | -3.79% |
Volume | 2,104 |
Open | 7.62 |
Previous Close | 7.73 |
Day's Range | 7.62 - 7.62 |
52-Week Low | 7.22 |
52-Week High | 8.94 |
Beta | 0.75 |
Holdings | 27 |
Inception Date | Apr 3, 2018 |
About HIG
Brompton Global Healthcare Income & Growth ETF is an exchange traded fund launched and managed by Brompton Funds Limited. The fund invests in public equity markets of global region. It invests in stocks of companies operating across health care sectors. It invests in growth and value stocks of large-cap companies. It employs fundamental analysis with bottom-up and top-down stock picking approach to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the MSCI World Health Care Index. Brompton Global Healthcare Income & Growth ETF was formed on September 24, 2015 and is domiciled in Canada.
Performance
HIG had a total return of -3.79% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.40%.
Top 10 Holdings
45.39% of assetsName | Symbol | Weight |
---|---|---|
UnitedHealth Group Incorporated | UNH | 5.09% |
Cardinal Health, Inc. | CAH | 4.85% |
Boston Scientific Corporation | BSX | 4.71% |
Bristol-Myers Squibb Company | BMY | 4.60% |
Eli Lilly and Company | LLY | 4.45% |
Sanofi | SNY | 4.45% |
McKesson Corporation | MCK | 4.42% |
Johnson & Johnson | JNJ | 4.32% |
Vertex Pharmaceuticals Incorporated | VRTX | 4.28% |
Amgen Inc. | AMGN | 4.23% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
May 30, 2025 | 0.055 CAD | Jun 13, 2025 |
Apr 30, 2025 | 0.055 CAD | May 14, 2025 |
Mar 31, 2025 | 0.055 CAD | Apr 14, 2025 |
Feb 28, 2025 | 0.055 CAD | Mar 14, 2025 |
Jan 31, 2025 | 0.055 CAD | Feb 14, 2025 |
Dec 31, 2024 | 0.055 CAD | Jan 15, 2025 |